# EVRYSDI

NDC: 50242-202
Generic name: Risdiplam
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250211

FDA application: NDA219285

## Active ingredients

- RISDIPLAM: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-202"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-202
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eceb9a99-7191-4be5-87c3-0102707cf98e